Endobiotech

8 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• LABELING8 refused lines

  Fair Packaging and Labeling Act

  The package appeared not to meet the Fair Packaging and Labeling Act because of the placement, form, or contents of a required label statement.

• INCONSPICU4 refused lines

  Required information not conspicuous

  Information required on the label appeared not to be placed prominently or conspicuously enough to be read and understood by an ordinary consumer.

• UNSFDIETSP4 refused lines

  Dietary ingredient without safety assurance

  The product appeared to be a dietary supplement or dietary ingredient for which there is inadequate information to provide reasonable assurance that it does not present a significant or unreasonable risk of illness or injury.

Questions about Endobiotech

Is Endobiotech on an FDA import alert?

No listing for Endobiotech appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the Lithuania page.

Has FDA refused shipments from Endobiotech?

Yes. FDA refused 8 shipment lines from Endobiotech between July 12, 2017 and August 8, 2017. The most recent, on August 8, 2017, was fats and lipid substances, n.e.c., charged as UNSFDIETSP (dietary ingredient without safety assurance).

Why did FDA refuse Endobiotech's shipments?

The most frequent charges are LABELING (fair packaging and labeling act, 8 lines) and INCONSPICU (required information not conspicuous, 4 lines).

What is Endobiotech's FEI number?

Endobiotech's FDA Establishment Identifier (FEI) is 3012473778.